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ABSTRACT
Objectives: This research was designed to investigate the antidepressant activity of a few structurally related flavones (flavone, 3‑hydroxyflavone, and 
7‑hydroxyflavone) and the possible mechanisms involved.
Methods: Antidepressant activity was evaluated in mice by subjecting them to forced swim test and tail suspension test. The involvement of adrenergic, 
serotonergic, nitric oxide (NO), and opioid mechanisms was investigated using suitable interacting chemicals.
Results: Flavone, 3‑hydroxyflavone, and 7‑hydroxyflavone exhibited a significant and dose‑dependent reduction in total time of immobility in the 
forced swim test and tail suspension test. Pre‑treatment with alpha‑methyl‑para‑tyrosine and parachlorophenyl alanine attenuated the reduction in 
immobility period produced by flavone and its derivatives in forced swim test. Naloxone pre‑treatment partially reversed the effect of flavone while 
L‑arginine pre‑treatment did not alter their effect.
Conclusion: The investigated flavones exhibited promising antidepressant activity in both the animal models of depression. However, the flavone 
compounds did not alter the motor coordination and ambulatory behavior in the Rotarod and locomotor activity test. The participation of serotonergic, 
adrenergic, and opioid mechanism in the antidepressant activity of these compounds was elucidated from the results, and the role of NO pathway 
was excluded.
Keywords: Antidepressant activity, Flavone, Forced swim test, Tail suspension test.
INTRODUCTION
Depression is often under diagnosed and undertreated. The current 
antidepressant drugs such as monoamine oxidase inhibitors, selective 
serotonin reuptake inhibitors (SSRIs), tricyclic antidepressants, 
and inhibitors of norepinephrine and serotonin uptake delay the 
onset of resolution of depressive symptoms and cause serious 
adverse effects. An estimated 29–46% of patients treated for major 
depressive disorder have either a partial response or no response 
at all to antidepressive treatment. Hence, there is a continued need 
to search for an antidepressant drug which is more effective and 
safe [1]. Hypericum Perforatum, a European traditional medicine, has 
been extensively investigated and clinically evaluated in comparison 
with standard antidepressant drugs [2]. The medicinal plants are not 
only always free of side effects, for example, H. perforatum though 
exhibiting antidepressant‑like actions, but also has some of its serious 
side effects [3]. Many plants used in the Indian traditional system of 
medicine have also been scientifically investigated for their effect 
in animal models of depression, and the mechanisms of action have 
also been explored [4]. This observation kindled an interest whether 
flavonoids could be a potential source for antidepressant drugs [5]. 
Flavonoids such as rutin [6], quercetin [7‑9], and naringenin[10] 
that are widely distributed in many plants have been investigated 
for potential antidepressant effects. Most of the above compounds 
are polysubstituted flavones and it was considered interesting to 
explore the antidepressant activity of the basic flavone nucleus and 
its simpler derivatives. Hence, in this research, flavone and two of its 
mono‑hydroxy derivatives have been investigated for considerable 
antidepressant effect in mice by subjecting them to forced swim test 
and tail suspension test. In addition, the possible mechanisms involved 




For the current study, male adult Swiss albino mice weighing 25–30 g 
were selected and were sourced from the institutional animal house. On 
a natural day and night cycle, the animals were housed in a controlled 
environment with food and water available ad libitum. In all the 
experiments, each group consisted of six animals. Each animal was 
used only once. All the experiments were carried out between 9:00 and 
13:00 h to avoid circadian variation and to maintain uniformity. The 
experimental protocol was approved by the Institutional Animal Ethics 
Committee (BR/HOS/85/2013/F‑378 and KN/COL/3401/2014).
Drugs and chemicals
The compounds used in the study are flavone, 3‑hydroxyflavone, and 
7‑hydroxyflavone, and its hydroxy derivatives were prepared as a fine 
suspension in 2% carboxymethyl cellulose and injected i.p. in doses of 
5, 10, and 20 mg/kg, 30 min before the test procedures. The doses were 
selected based on the pilot study. Imipramine (Torrent Pharmaceuticals, 
India), para‑chlorophenylalanine (PCPA) (Sigma‑Aldrich, St. Louis, MO, 
USA), alpha‑methyl‑para‑tyrosine (AMPT) (Sigma‑Aldrich, St. Louis, 
MO, USA), naloxone hydrochloride (Endo Labs USA), L‑arginine (Tokyo 
Chemical Industry, Japan), and diazepam (Neon Laboratories Ltd., 
Mumbai) were used in the present study.
Ambulatory behavior by actophotometer test
Mice were observed for ambulatory activity using an 
actophotometer (INCO, India). The activity of the animals was recorded 
by interruption of light beams passing through the square chambered 
apparatus. Mice were treated with flavone, 3‑hydroxyflavone, or 
7‑hydroxyflavone in a dose of 20 mg/kg i.p. or vehicle and placed in 
the actophotometer after 30 min. The number of beam breaks was 
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recorded for 5 min [11]. The instrument was cleaned with cotton swab 
dipped in spirit in between the observations. Diazepam (2 mg/kg i.p) 
was used for comparison in a separate group of mice.
Motor coordination by Rotarod test
The effect on motor coordination was evaluated by treating the mice 
with flavone, 3‑hydroxyflavone, or 7‑hydroxyflavone in a dose of 
20 mg/kg i.p. or vehicle, 30 min before being tested on a Rotarod [12]. 
The apparatus (INCO, India) consists of a bar with a diameter of 2.5 cm 
subdivided into two compartments. The bar rotates at a constant 
speed of 15 revolutions/min and the ability of the animal to remain on 
the rotating rod (balancing time) was measured and compared with 
vehicle‑treated animals. The cut‑off time employed was 120 s. A group 
of mice was treated with diazepam 2 mg/kg i.p. for comparison.
Antidepressant activity by forced swim test[13]
In this test, the mouse is forced to swim inside a vertical open 
cylindrical container (height 25 cm and diameter 10 cm) with 19 cm 
of water (depth) and the temperature was maintained at 25 ± 1°C. 
Initially, the mouse swims vigorously in circles and tries to climb the 
wall or dive to the bottom. After a minute, the activity begins to subside 
and replaced with phases of immobility or floating of increasing 
length, with only minimal movements to keep its head above the 
water level. The total duration of immobility in seconds was recorded 
during a 6‑min period in which the 1st min was given as the time for 
the animal to get adapted to the new environment. Hence, no readings 
were taken during the 1st min. A decline in the duration of immobility 
is indicative of an antidepressant effect. Flavone, 3‑hydroxyflavone, or 
7‑hydroxyflavone was administered i.p in doses of 5, 10, or 20 mg/kg to 
different groups of mice, 30 min before the test. Imipramine 20 mg/kg 
i.p was used for comparison in a separate group of mice. The doses of 
flavone compounds selected for the study were based on the pilot study 
conducted.
Antidepressant activity by tail suspension test[14]
In this method, a mouse is suspended in a rod of 10 cm length attached 
perpendicularly to the vertical iron stand, 50 cm above the floor by 
adhesive tape placed approximately 1 cm from the tip of the tail in a 
dim light and silent environment. The animal remains immobile after 
active and unsuccessful attempts to escape when suspended by tail. The 
animal was observed for 6 min and the immobility time was recorded. 
Effective antidepressants reduce the immobility time of the animals. 
Flavone, 3‑hydroxyflavone, or 7‑hydroxyflavone was injected i.p to 
different groups of mice in doses of 5, 10, or 20 mg/kg. Animals were 
subjected to the test 30 min after administration of the test compounds. 
Imipramine 20 mg/kg i.p was used as a standard drug for comparison.
Investigations on the mechanism of action
Further, experiments were tried to elucidate the mechanisms by 
which flavone and its derivatives exerted their antidepressant activity. 
A single dose of flavone (20 mg/kg), 3‑hydroxyflavone (20 mg/kg), or 
7‑hydroxyflavone (20 mg/kg) was used for this purpose in the forced 
swim test in mice.
Serotonergic system
To assess the possible role of serotonergic system in the antidepressant 
effect of flavone and its derivatives, animals were pretreated with a 5‑HT 
synthesis inhibitor, PCPA, 100 mg/kg i.p, for 4 consecutive days [6]. On 
the 5th day, that is, 24 h after the last PCPA injection, the animals were 
given an injection of flavone or its derivatives in a dose of 20 mg/kg i.p 
and were employed to forced swim test after 30 min.
Adrenergic system
To witness the contribution of adrenergic system, mice were pretreated 
with AMPT, an inhibitor of the enzyme tyrosine hydroxylase, 100 mg/kg 
i.p. [6]. After 4 h, they received flavone or its hydroxy derivatives in a dose 
of 20 mg/kg i.p and were subjected to forced swim test, 30 min later.
Opioid mechanism
The participation of opioid system in the antidepressant action of 
flavone and its derivatives was investigated by pre‑treating the mice 
with naloxone 5 mg/kg i.p [15], and after 15 min, the animals received 
an injection of flavone or its derivatives in a dose of 20 mg/kg i.p. The 
antidepressant effect was recorded 30 min later using forced swim test.
Nitric oxide (NO) mechanism
Pre‑treatment with L‑arginine (750 mg/kg i.p), a NO precursor, 15 min 
before flavone or its derivatives was attempted to investigate the role 
of NO pathway in the antidepressant effect of these compounds [16]. 
Flavone and its derivatives were used in a dose of 20 mg/kg i.p.
Statistical analysis
One‑way ANOVA followed by Dunnett’s t‑test was used using SPSS 
16 software to analyze the data obtained from various experiments. 
A probability value <5% was considered to be statistically significant. 
Results are as mean ± standard error mean.
RESULTS
Ambulatory behavior and motor coordination
The balancing time of mice on a Rotarod and the activity score in 
the actophotometer were significantly reduced by diazepam (2 mg/
kg i.p) treatment. Flavone and its hydroxy derivatives in a dose 
of 20 mg/kg i.p did not alter the activity score of mice in the 
actophotometer or the balancing time on the Rotarod apparatus when 
compared to vehicle‑treated animals. Hence, the ambulatory behavior 
and motor coordination of mice were not significantly influenced by 
flavone and its hydroxy derivatives (Table 1).
Forced swim test
The immobility period recorded in vehicle‑treated control animals 
was 195.07 ± 5.8 s. A significant reduction in immobility period was 
noted in imipramine (20 mg/kg)‑treated mice and the mean value was 
3.47 ± 1.49 s. A dose proportionate reduction in immobility period 
compared to vehicle treatment was observed after treatment with 
different doses (5, 10, and 20 mg/kg i.p) of flavone, 3‑hydroxyflavone, 
and 7‑hydroxyflavone. The percentage reduction in immobility period 
after treatment with different doses of the above test compounds was 
calculated in comparison with the vehicle treatment. The maximum 
reduction in immobility period in a dose of 20 mg/kg of flavone, 
3‑hydroxyflavone, and 7‑hydroxyflavone was 88.49%, 45.48%, and 
55.88%, respectively, while imipramine treatment produced 98% 
inhibition (Table 2).
Tail suspension test
The mean period of immobility in control group of animals 
was 206.85 ± 5.76 s which was decreased to 14.84 ± 1.41 s in 
imipramine (20 mg/kg)‑treated animals and the reduction was 92% 
Table 1: Effect of flavone and its monohydroxy derivatives on ambulatory behavior and motor performance of mice
Treatment groups (mg/kg i.p) Activity score in the actophotometer (5 min) Balancing time on the Rotarod (120 s)
Vehicle 464.33±9.34 120.00±0.00
Diazepam (2) 163.83±2.73a 3.66±0.66a
Flavone (20) 446.00±9.23 120.00±0.00
3‑hydroxyflavone (20) 452.00±7.42 120.00±0.00
7‑hydroxyflavone (20) 467.50±8.12 120.00±0.00
ap<0.05 in comparison to vehicle (one‑way ANOVA followed by Dunnett’s t‑test)
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when compared to vehicle‑treated animals. A dose‑dependent reduction 
in immobility period was observed in animals treated with increasing 
doses of flavone, 3‑hydroxyflavone, and 7‑hydroxyflavone (5, 10, and 
20 mg/kg i.p). The percentage reduction in immobility period was 
calculated in comparison with the vehicle treatment. The maximum 
reduction in immobility period in a dose of 20 mg/kg of flavone, 
3‑hydroxyflavone, and 7‑hydroxyflavone was 73.97%, 51.77% and 
59.27%, respectively (Table 3).
Investigations on the mechanism of action
Involvement of serotonergic system
Flavone, 3‑hydroxyflavone, and 7‑hydroxyflavones (20 mg/kg) per se 
significantly decreased the immobility time of mice in forced swim 
test compared with vehicle treatment. However, PCPA pre‑treatment 
completely reversed the reduction in immobility period produced by 
the above compounds in forced swim test (Table 4).
Involvement of adrenergic system
Pre‑treatment with AMPT did not significantly alter the period 
of immobility in vehicle‑treated control animals. However, in 
AMPT‑pretreated animals, the magnitude of reduction in immobility time 
due to flavone and its derivatives was significantly attenuated (Table 5).
Involvement of opioid system
Naloxone (5 mg/kg i.p) treatment per se did not significantly alter the 
immobility period of mice in forced swim test. However, a partial but 
significant reversal of the reduction of immobility period of mice was 
evident in animals treated with flavone and its derivatives (Table 6).
Involvement of L‑arginine‑NO system
L‑arginine (750 mg/kg i.p) pre‑treatment did not significantly modify 
the immobility period of vehicle‑treated mice in forced swim test. The 
reduction in immobility period showed by flavone and its hydroxy 
derivatives was also not significantly modified by treatment with 
L‑arginine (Table 7).
DISCUSSION
Mood and anxiety disorders are the most common psychiatric disorder 
widely presented to clinicians. Evidence are accruing that some 
natural products such as S‑adenosine methionine, 1‑methylfolate, 
and omega‑3 fatty acids may be useful in depression [17]. Thus, there 
appear to be multiple novel targets for the new drug development to 
the treatment of depressive illness. It is pertinent to mention here that 
flavonoids are ubiquitous natural compounds endowed with many 
potential therapeutic benefits. Their opioid‑like analgesic effect has 
been identified earlier [18]. A few recent studies have identified some 
flavone compounds such as rutin [6‑9] and naringenin[10] to be effective 
in animal models of depression. This research was undertaken to 
investigate the antidepressant activity of basic flavone nucleus and two 
of its monohydroxy derivatives.
The investigated compounds, such as flavone, 3‑hydroxyflavone, and 
7‑hydroxyflavone, did not alter either the ambulatory activity or the 
balancing time of mice on a Rotarod. Assessment of motor coordination 
and ambulatory activity is essential because the important parameter 
monitored for antidepressant activity in both forced swim test and tail 
suspension test is the period of immobility. If the test compounds are 
going to affect the motor coordination and ambulatory activity, it may 
produce false positive/negative results [19]. The present results on 
flavone derivatives exclude such a possibility.
The results of the present study clearly depict that the time of 
immobility in the forced swim test as well as in the tail suspension test 
is decreased in a dose‑dependent fashion in mice treated with flavone, 
3‑hydroxyflavone, or 7‑hydroxyflavone (Tables 2 and 3). The reduction 
in immobility time was evidently significant even in a dose of 5 mg/kg of 
all the tested compounds in forced swim test. In the tail suspension test 
also, a similar trend has been observed except for 7‑hydroxyflavone. The 
above findings clearly indicate an antidepressant‑like effect of flavone, 
3‑hydroxyflavone, and 7‑hydroxyflavone. It is important to point out 
that the antidepressant effect for these compounds was clearly evident 
even in a dose as low as 5 mg/kg. Further, increase in doses augmented 
the antidepressant effect of these flavones as observed from the results 
of forced swim test and tail suspension test (Tables 2 and 3).
Mechanisms involved in the antidepressant effect of investigated 
flavones
It was considered interesting to investigate the possible mechanisms 
through which the antidepressant effects of flavones are mediated. 
The probable roles played by serotonergic, adrenergic, opioid, and NO 
pathways in the antidepressant effect of flavones have been investigated 
in the present study. PCPA, a tryptophan hydroxylase enzyme inhibitor 
when administered for 4 days in mice, is known to deplete the 
endogenous stores of serotonin by about 60% without altering the levels 
of noradrenaline and dopamine [20,21]. Pre‑treatment with PCPA in 
Table 2: Effect of flavone and its monohydroxy derivatives on mice in forced swim test
Dose (mg/kg i.p) Period of immobility (s)
Flavone 3‑hydroxyflavone 7‑hydroxyflavone
Vehicle 195.07±5.8 195.07±5.8 195.07±5.8
Imipramine (%) 3.47±1.49 (98) 3.47±1.49 (98) 3.47±1.49 (98)
5 mg/kg 138.86±2.68a (40.42) 157.69±1.78a (19.16) 171.80±4.23a (11.92)
10 mg/kg 119.40±1.77a (38.79) 137.48±8.7a (29.52) 111.16±4.69a (43.01)
20 mg/kg 22.45±3.85a (88.49) 106.34±6.03a (45.48) 86.05±2.14a (55.88)
ap<0.05 in comparison to vehicle (one‑way ANOVA followed by Dunnett’s t‑test). The values in brackets indicate the percentage reduction of immobility duration 
compared to vehicle
Table 3: Effect of flavone and its monohydroxy derivatives on mice in tail suspension test
Dose mg/kg i.p Period of immobility (s)
Flavone 3‑hydroxyflavone 7‑hydroxyflavone
Vehicle 206.85±5.76 206.85±5.76 206.85±5.76
Imipramine (%) 14.84±1.41 (92) 14.84±1.41 (92) 14.84±1.41 (92)
5 mg/kg 171.52±3.83a (17.08) 197.15±1.56 (4.68) 174.18±2.66a  (15.79)
10 mg/kg 154.75±5.81a (25.18) 184.57±7.67a (10.77) 140.13±2.97a (32.25)
20 mg/kg 53.84±4.85a (73.97) 99.76±7.68a (51.77) 84.23±4.14a (59.27)
ap<0.05 in comparison to vehicle (one‑way ANOVA followed by Dunnett’s t‑test). The values in brackets indicate the percentage reduction of immobility duration 
compared to vehicle
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mice has been shown to alter the response to SSRIs such as fluoxetine 
and citalopram [22]. The results of the present research indicate that 
PCPA pre‑treatment effectively reversed the reduction in immobility 
period produced by flavone, 3‑hydroxyflavone, and 7‑hydroxyflavone 
in the forced swim test (Table 4). This observation clearly indicates the 
role of serotonergic mechanisms in the antidepressant effect of all the 
three investigated flavones. Flavonoids such as rutin [6], vitexin [23], 
liquiritin, and isoliquiritin[24] and flavonoids from H. perforatum[2] have 
been earlier shown to involve serotonergic pathways in mediating their 
antidepressant effect. The present result is in agreement with these 
findings, and serotonergic mechanism may be considered as an important 
mode of action in the antidepressant effect of flavonoids in general.
The role of adrenergic system in the effect of antidepressant drugs 
is generally studied by employing tyrosine hydroxylase inhibitor 
AMPT, which has been shown to reduce the levels of dopamine and 
nonadrenaline to an extent of 57 and 53%, respectively, in mice without 
altering the levels of serotonin [25]. The results of the present study 
indicate that prior administration of AMPT significantly reversed 
the decrease in immobility period of mice produced by flavone, 
3‑hydroxyflavone, and 7‑hydroxyflavone treatment in forced swim 
test (Table 5). This observation shows the valid role for adrenergic 
system in the antidepressant effect of the above flavones. Previous 
studies on flavonoids such as rutin 4, liquiritin and isoliquiritiin [24], 
and vitexin[23] and flavonoids from H. perforatum[2] indicated an 
involvement of adrenergic mechanism in their antidepressant effect. 
The present results on flavone and its monohydroxy derivatives are in 
agreement with the earlier reports.
The µ‑opioid receptors are implicated in depression and stress states 
due to their dense distribution in brain areas associated with stress and 
emotion. Serum β‑endorphin levels have been shown to be decreased 
in patients with severe depression [26,27]. Amentoflavone and 
hyperoside present in H. perforatum have κ antagonist activity in vitro, 
and Katavic also suggested flavonoid core as a future new scaffold for 
the development of opioid receptor ligands [28]. Moreover, central 
administration of endogenous peptides such as endomorphin‑1 and 
endomorphin‑2 has been shown to possess antidepressant activity 
in mice [15]. All these evidence indicate a prominent role for opioid 
system in the development of depression. Flavone and many of its 
hydroxy derivatives were found to possess opioid‑mediated analgesic 
action in mice. Hence, it was considered interesting to investigate the 
possible participation of opioid mechanism in the antidepressant effect 
of the investigated flavones. Naloxone, a non‑specific opioid antagonist, 
was used for this purpose. It is clear from the results (Table 6) that 
naloxone administration partially reversed the reduction in immobility 
period produced by flavone, 3‑hydroxyflavone, and 7‑hydroxyflavone. 
There is no complete suppression of the effect of flavones with naloxone 
pre‑treatment. The results, thus, depict that the antidepressant effect of 
the investigated flavones at least in part could be due to the involvement 
of opioid mechanism.
The participation of L‑arginine‑NO pathway in the modulation of 
depression has been reported earlier by Da Silva et al. [29]. Melatonin 
has been shown to exert an antidepressant effect through an interaction 
with NMDA receptors and L‑arginine‑NO pathway [15]. A flavanone 
glycoside hesperidin exhibited antidepressant activity involving 
NO ‑GMP pathway [30]. These authors provided evidence that NO donor 
L‑arginine could attenuate the antidepressant effect of hesperidin. 
A recent report identified the role of NO modulatory mechanism in 
the neuroprotective effect of rutin, and L‑arginine pre‑treatment 
has been shown to significantly reverse the protective effect of rutin 
against immobilization stress‑induced anxiety‑like behavior [31]. In 
light of aforementioned information, it was considered interesting 
to investigate the role of NO in the antidepressant effect of flavones. 
A NO donor L‑arginine was employed for this purpose [32]. However, 
pre‑treatment with L‑arginine did not significantly modify the 
reduction in immobility period affected by flavone, 3‑hydroxyflavone, 
or 7‑hydroxyflavone. The unaltered response of the above flavones in 
the presence of L‑arginine indicates that NO mechanism may not play a 
role in the antidepressant effect of these compounds.
CONCLUSION
The present study has identified the novel antidepressant activity 
of the basic flavone scaffold and its monohydroxy derivatives. The 
major participation of serotonergic and adrenergic mechanisms and 
partial role of opioid mechanism in the antidepressant effect of flavone 
compounds were also revealed. Since multiple neurotransmitter 
systems are involved in the antidepressant effect of the flavone 
compounds, the serious side effects are inevitable. Hence, the safety 
profile of the compound needs to be evaluated.
Table 4: Effect of PCPA pre‑treatment on flavone and its 
monohydroxy derivatives on mice in forced swim test




period (s) with 
PCPA
Vehicle 195.07±5.8 205.92±5.35
Flavone (20) 22.45±3.85a 156.05±1.64b
3‑hydroxyflavone (20) 106.34±6.03a 192.43±1.80b
7‑hydroxyflavone (20) 86.05±2.14a 201.48±0.43b
ap<0.05 in comparison to vehicle (one‑way ANOVA followed by Dunnett’s t‑test), 
bp<0.05 compared to PCPA 100 mg/kg i.p pre‑treated animals (one‑way ANOVA 
followed by Dunnett’s t‑test). PCPA: Parachlorophenylalanine
Table 5: Effect of AMPT pre‑treatment on flavone and its 
monohydroxy derivatives on mice in forced swim test
Treatment (mg/kg i.p) Immobility 
time (s) without 
AMPT
Immobility 
time (s) with 
AMPT
Vehicle 195.07±5.8 205.92±5.35
Flavone (20) 22.45±3.85a 156.05±1.64b
3‑hydroxyflavone (20) 106.34±6.03a 192.43±1.80b
7‑hydroxyflavone (20) 86.05±2.14a 201.48±0.43b
ap<0.05 in comparison to vehicle (one‑way ANOVA followed by Dunnett’s t‑test). 
bp<0.05 compared to AMPT‑pretreated animals 100 mg/kg i.p (one‑way ANOVA 
followed by Dunnett’s t‑test). AMPT: Alpha‑methyl‑para‑tyrosine
Table 6: Effect of naloxone pre‑treatment on flavone and its 
monohydroxy derivatives on mice in forced swim test
Treatment (mg/kg i.p) Immobility 
time (s) without 
naloxone
Immobility 
time (s) with 
naloxone
Vehicle 195.07±5.8 196.95±0.97
Flavone (20) 22.45±3.85a 35.10±2.33b
3‑hydroxyflavone (20) 106.34±6.03a 136.73±3.99b
7‑hydroxyflavone (20) 86.05±2.14a 117.11±2.43b
ap<0.05 in comparison to vehicle (one‑way ANOVA followed by Dunnett’s 
t‑test). bp<0.05 compared to naloxone pretreated animals 5 mg/kg i.p (one‑way 
ANOVA followed by Dunnett’s t‑test)
Table 7: Effect of L‑arginine pre‑treatment on flavone and its 
monohydroxy derivatives on mice in forced swim test
Treatment (mg/kg i.p) Immobility 
time (s) without 
L‑arginine
Immobility 
time (s) with 
L‑arginine
Vehicle 195.07±5.8 200.57±2.93
Flavone (20) 22.45±3.85a 25.67±0.68
3‑hydroxyflavone (20) 106.34±6.03a 110.29±2.05
7‑hydroxyflavone (20) 86.05±2.14a 79.32±3.18
ap<0.05 compared to vehicle (one‑way ANOVA followed by Dunnett’s t‑test)
517
Asian J Pharm Clin Res, Vol 12, Issue 2, 2019, 513-517
 Shanmugapriyan et al. 
ACKNOWLEDGMENT
Authors are thankful to Dr. Chandran, veterinarian, and Mrs. Sharmaila 
for their technical support.
AUTHORS’ CONTRIBUTIONS
Dr. Shanmugapriyan S performed the study and collected the data. 
Dr. Viswanathan S designed the analysis. Dr. Jaikumar S and Dr. Parimala 
K performed the analysis. Dr. Shanmugapriyan S and Dr. Rajesh M wrote 
the manuscript.
CONFLICTS OF INTEREST
Authors declare that they have no conflicts of interest.
REFERENCES
1. Dattatray BP, Padmaja AM, Nirmala NR. Antidepressant activity 
of aqueous extracts of fruits of Terminalia chebula and Phyllanthus 
emblica in behavioural models of depression: Involvement of 
monoaminergic system. Int J Pharm Pharm Sci 2014;6:615‑20.
2. Nathan PJ. Hypericum perforatum (St john’s wort): A non‑selective 
reuptake inhibitor? A review of the recent advances in its pharmacology. 
J Psychopharmacol 2001;15:47‑54.
3. Rodríguez‑Landa JF, Contreras CM. A review of clinical and 
experimental observations about antidepressant actions and side 
effects produced by Hypericum perforatum extracts. Phytomedicine 
2003;10:688‑99.
4. Arya A, Verma P. An emerging role of herbal therapy in depression. Int 
J Drug Discov Herbal Res 2012;2012:282‑95.
5. German‑Ponciano LJ, Rosas‑Sánchez GU, Rivadeneyra‑Domínguez E, 
Rodríguez‑Landa JF. Advances in the preclinical study of some 
flavonoids as potential antidepressant agents. Scientifica (Cairo) 
2018;2018:2963565.
6. Machado DG, Bettio LE, Cunha MP, Santos AR, Pizzolatti MG, 
Brighente IM, et al. Antidepressant‑like effect of rutin isolated from 
the ethanolic extract from Schinus molle L. In mice: Evidence for the 
involvement of the serotonergic and noradrenergic systems. Eur J 
Pharmacol 2008;587:163‑8.
7. Lu YH, Du CB, Liu JW, Hong W, Wei DZ. Neuroprotective effects 
of Hypericum perforatum on trauma induced by hydrogen peroxide in 
PC12 cells. Am J Chin Med 2004;32:397‑405.
8. Borrelli F, Izzo AA. Herb‑drug interactions with st john’s 
wort (Hypericum perforatum): An update on clinical observations. 
AAPS J 2009;11:710‑27.
9. Kawabata, K, Kawai, Y, Terao, J. Suppressive effect of quercetin on 
acute stress‑induced hypothalamic‑pituitary‑adrenal axis response in 
wistar rats. J Nutr Biochem 2010;21:374‑80.
10. Yi LT, Li CF, Zhan X, Cui CC, Xiao F, Zhou LP, et al. Involvement of 
monoaminergic system in the antidepressant‑like effect of the flavonoid 
Naringenin in mice. Prog Neuropsychopharmacol Biol Psychiatry 
2010;34:1223‑8.
11. Mahendran G, Thamotharan G, Sengottuvelu S, Bai VN. Evaluation of 
anticonvulsant, sedative, anxiolytic, and phytochemical profile of the 
methanol extract from the aerial parts of Swertia corymbosa (Griseb.) 
wight ex C.B. Clarke. Biomed Res Int 2014;2014:542385.
12. Jürgensen S, Dalbó S, Angers P, Santos AR, Ribeiro‑do‑Valle RM. 
Involvement of 5‑HT2 receptors in the antinociceptive effect of 
Uncaria tomentosa. Pharmacol Biochem Behav 2005;81:466‑77.
13. Porsolt RD, Bertin A, Jalfre M. Behavioural despair in rats and 
mice: Strain differences and the effects of imipramine. Eur J Pharm 
1978;51:291‑4.
14. Steru L, Chermat R, Thierry B, Simon P. The tail suspension 
test: A new method for screening antidepressants in mice. 
Psychopharmacology (Berl) 1985;85:367‑70.
15. Fichna J, Janecka A, Costentin J, Do Rego JC. The endomorphin 
system and its evolving neurophysiological role. Pharmacol Rev 
2007;59:88‑123.
16. Mantovani M, Pértile R, Calixto JB, Santos AR, Rodrigues AL. 
Melatonin exerts an antidepressant‑like effect in the tail suspension test 
in mice: Evidence for involvement of N‑methyl‑D‑aspartate receptors 
and the L‑arginine‑nitric oxide pathway. Neurosci Lett 2003;343:1‑4.
17. O’Donnell JM, Shelton RC. Drug therapy of depression and anxiety 
disorders. In: Goodman and Gillman’s‑The Pharmacological Basis of 
Therapeutics. 12th ed. New Delhi: McGraw Hill; 2011. p. 397‑415.
18. Viswanathan S, Sambantham PT, Reddy K, Kameswaran L. 
Gossypin‑induced analgesia in mice. Eur J Pharmacol 1984;98:289‑91.
19. Bogdanova OV, Kanekar S, D’Anci KE, Renshaw PF. Factors 
influencing behavior in the forced swim test. Physiol Behav 
2013;118:227‑39.
20. Redrobe JP, Bourin M, Colombel MC, Baker GB. 
Psychopharmacological profile of the selective serotonin reuptake 
inhibitor, paroxetine: Implication of noradrenergic and serotonergic 
mechanisms. J Psychopharmacol 1998;12:348‑55.
21. Redrobe JP, Bourin M. Evidence of the activity of lithium on 5‑HT1B 
receptors in the mouse forced swimming test: Comparison with 
carbamazepine and sodium valproate. Psychopharmacology (Berl) 
1999;141:370‑7.
22. O’Leary OF, Bechtholt AJ, Crowley JJ, Hill TE, Page ME, Lucki I, et al. 
Depletion of serotonin and catecholamines block the acute behavioral 
response to different classes of antidepressant drugs in the mouse tail 
suspension test. Psychopharmacology (Berl) 2007;192:357‑71.
23.	 Can	ÖD,	Demir	Özkay	Ü,	Üçel	Uİ.	Anti‑depressant‑like	effect	of	vitexin	
in BALB/c mice and evidence for the involvement of monoaminergic 
mechanisms. Eur J Pharmacol 2013;699:250‑7.
24. Wang X, Zhang L, Hua L, Xing D, Du L. Effect of Flavonoids in 
Scutellariae radix on depression‑like behaviour and brain rewards: 
Possible in dopamine system. Tsinghua Sci Technol 2010;15:460‑6.
25. Mayorga AJ, Dalvi A, Page ME, Zimov‑Levinson S, Hen R, Lucki I, et al. 
Antidepressant‑like behavioral effects in 5‑hydroxytryptamine (1A) 
and 5‑hydroxytryptamine (1B) receptor mutant mice. J Pharmacol Exp 
Ther 2001;298:1101‑7.
26. Darko DF, Risch SC, Gillin JC, Golshan S. Association of 
beta‑endorphin with specific clinical symptoms of depression. Am J 
Psychiatry 1992;149:1162‑7.
27.	 Djurović	D,	Milić‑Askrabić	 J,	Majkić‑Singh	N.	Serum	beta‑endorphin	
level in patients with depression on fluvoxamine. Farmaco 1999;54:130‑3.
28. Paramdeep S, Damanpreet S, Rajesh KG. Phytoflavonoids: 
Antiepileptics for the future. Int J Pharm Pharm Sci 2014;6:51‑66.
29. da Silva GD, Matteussi AS, dos Santos AR, Calixto JB, Rodrigues AL. 
Evidence for dual effects of nitric oxide in the forced swimming test 
and in the tail suspension test in mice. Neuroreport 2000;11:3699‑702.
30. Yildiz F, Erden BF, Ulak G, Utkan T, Gacar N. Antidepressant‑like 
effect of 7‑nitroindazole in the forced swimming test in rats. 
Psychopharmacology (Berl) 2000;149:41‑4.
31. Donato F, de Gomes MG, Goes AT, Filho CB, Del Fabbro L, 
Antunes MS, et al. Hesperidin exerts antidepressant‑like effects in acute 
and chronic treatments in mice: Possible role of l‑arginine‑NO‑cGMP 
pathway and BDNF levels. Brain Res Bull 2014;104:19‑26.
32. Machawal L, Kumar A. Possible involvement of nitric oxide mechanism 
in the neuroprotective effect of rutin against immobilization stress 
induced anxiety like behaviour, oxidative damage in mice. Pharmacol 
Rep 2014;66:15‑21.
